My RSS Feeds
Sangamo Biosciences (SGMO): High Potential Biotech Opportunity
See Rob_Cos's post on SGMO at Investor Village - good information on why SGMO is one of the key biotech stocks that you should begin adding to your portfolio. It's at a high - buy on the dips. But I didn't wait for a dip before I bought some last week. Glad I did!
Sangamo Biosciences has a group of technologies that really could represent game changers. Powerful opportunity.
My biotech picks continue have Celgene (CELG) as a foundation. This week - maybe today - offers another buying opportunity before the stream of expected news in the fall. I also like SGMO and OXGN (Oxigene). As a speculative, long-term investment, I also like GTCB. I also think Enzo Biosciences (ENZ) has become oversold. I expect it to return to nearly 18 in the next year from its current level of $12. I bought some last week around $11.